MedPath

A Pilot Study on Usefulness of Probe-based Confocal Laser Endomicroscopy Targeted Gastric Biopsy

Not Applicable
Completed
Conditions
Gastric Cancer
Interventions
Procedure: Probe-based confocal laser endomicroscopy
Procedure: White light endoscopy
Registration Number
NCT02089373
Lead Sponsor
Yonsei University
Brief Summary

The purpose of this study is to conduct a study on genetic pathology, obtaining of pure cancer tissues is mandatory. Although the endoscopy with biopsy has been a gold standard for diagnosing gastric cancer, percentage of cancer cells in biopsy samples is usually 30% or less. Recently, confocal laser endomicroscopy has been introduced for real-time histopathologic diagnosis in various cancers. The investigators aim to evaluate that biopsy using probe-based confocal laser endomicroscopy will increase the percentage of cancer cells in biopsy samples.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Age, between 20 and 80
  2. Initial-onset gastric cancer which would be treated with surgery
Read More
Exclusion Criteria
  1. Previous subtotal gastrectomy
  2. Pregnancy or breast milk feeding
  3. Active infection
  4. Significant cardiopulmonary disease
  5. Active hepatitis or severe hepatic dysfunction
  6. Severe renal dysfunction
  7. Severe bone marrow dysfunction
  8. Severe neurologic or psychotic disorder
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Probe-based confocal laser endomicroscopyProbe-based confocal laser endomicroscopy-
White light endoscopyWhite light endoscopy-
Primary Outcome Measures
NameTimeMethod
The percentage of cancer cells in biopsy samplesAfter 3 days from the end of the endoscopic submucosal dissection

The percentages of cancer cells in biopsy samples according to the method of endoscopic method, probe-based confocal laser endomicroscopy versus white light endosocpy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institutional Review Board in Severance Hospital

🇰🇷

Seodaemun-gu, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath